Helicobacter Pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures

Journal of Physiology and Pharmacology

Volumn 61, Issue 4, 2010, Pages 437-442

  Grebowska, A ^a   Moran, A P ^b   Bielanski, W ^c   Matusiak, A ^a   Rechcinski, T ^d   Rudnicka, K ^a   Baranowska, A ^d   Rudnicka, W ^a   Chmiela, M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Helicobacter pylori; Lipopolysaccharide (LPS); Lymphocyte proliferation; Macrophages

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HELICOBACTER PYLORI LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKOCYTE ADHERENCE; LEUKOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MIDDLE AGED;

EID: 77957099451     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Warren JM, Marshall BJ. Unidentified curved bacilli on the gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275.
2. Mahdavi J, Sonden B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297: 573-578.
3. Pflock M, Kennard S, Finsterer N, Beier D. Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J Biotechnol 2006; 126: 52-60.
4. Wu AM, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-821.
5. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301: 1099-1102.
6. Torres VJ, Van Compernolle SE, Sundrud MS, Unutzman D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol 2007; 179: 5433-5440.
7. Moran AP, Knirel YA, Senchenkova SN, et al. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis (x) and Lewis (y) expression by H. pylori lipopolysaccharides. J Biol Chem 2002; 277: 5785-5795.
8. Skoglund A, Backhed HK, Nilsson Ch, Bjorkholm B, Normark S, Engstrand L. A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. PLoS 2009; 4: e5885.
9. Pohl MA, Romero-Gallo J, Guruge JL, Tse DB, Gordon JL, Blaser MJ. Host-dependent lewis (le) antigen expression in Helicobacter pylori cells recovered from Leb-transgenic mice. J Exp Med 2009; 206: 3061-3072.
10. Bergman MP, Engering A, Amits HH, et al. Helicobacter pylori modulated the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004; 200: 979-990.
11. 13C urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 545-553.
12. Rechcinski T, Chmiela M, Malecka-Panas E, Planeta-Malecka I, Rudnicka W. Serological indicators of Helicobacter pylori infections in adult dyspeptic patients and healthy blood donors. Microbiol Immunol 1997; 41: 387-393.
13. Moran AP, Helander IM, Kosunen TU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol 1992; 174: 1370-1377.
14. Gery J, Kruger J, Spiesel SZ. Stimulation of B-lymphocytes by endotoxin. J Immunol 1972; 108: 1088-1091.
15. Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997; 185: 2089-2094.
16. Khamri W, Moran AP, Worku ML, et al. Variations of Helicobacter pylori lipoplysaccharide to evade the innate immune component surfactant protein D. Infect Immun 2005; 73: 7677-7686.
17. Smith MF Jr, Mitchell A, Li G, et al. Toll-like receptor TLR2, and TLR5 but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278: 32552-32560.
18. Mattern T, Thanhauser A, Reiling N, et al. Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol 1994; 153: 2996-3004.
19. Rudnicka W, Jarosinska A, Bak-Romaniszyn L, et al. Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children. FEMS Immunol Med Microbiol 2003; 36: 141-145.
20. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 2000; 60: 6265-6272.
21. Bosco MC, Espinoza-Delgado I, Rowe TK, Halabarba MG, Longo DL., Varesio L. Functional role for the myeloid differentiation antigen CD14 in the activation human monocytes by IL-2. J Immunol 1997; 159: 2922-2931.
22. Paziak-Domanska B, Chmiela M, Jarosinska A, Rudnicka W. Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cell Immunol 2000; 202: 136-139.
23. Sundrud MS, Torres VJ, Unutzman D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. PNAS 2004; 101: 7727-7732.
24. Zabaleta J, McGee DJ, Zea AH, et al. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR ζ-chain (CD3 ζ). J Immunol 2004; 173: 586-593.
25. Schmees C, Prinz C, Treptan T, et al. Inhibition of T cell proliferation by Helicobacter pylori gamma - glutamyl transpeptidase. Gastroenterology 2007; 132: 1820-1833.
26. Gerhard M, Schmees C, Voland P, et al. A secreted lowmolecular weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology 2005; 128: 1327-1339.
27. Heine H, Rietschel ET, Ulmer AJ. The biology of endotoxin. Mol Biotechnol 2001; 19: 279-289.
28. Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancer via the lipopolysaccharide Toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res 2008; 14: 2909-2917.
29. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express Tolllike receptors and are activated by lipoplysaccharide. J Exp Med 2003; 197: 403-411.
30. Raghavan S, Holmgren J. CD4+CD25 suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol 2005; 44: 121-127.
31. Stuller KA, Ding H, Redline RW, Czinn S, Blanchard TG. CD25+ T cells induce Helicobacter pylori specific CD25 T cell anergy but are not required to maintain persistent hyporesponsivenes. Eur J Immunol 2008; 38: 3426-3435.
32. Beswick EJ, Pinchuk IV, Das S, Powell DW, Reyers VE. Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+CD25+Foxp3+ regulatory T cells. Infect Immun 2007; 75: 4334-4341.